Octave Specialty Group (OSG) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Aug, 2026Executive summary
Total revenue for Q2 2026 increased 51% year-over-year to $83.0 million, driven by Insurance Distribution segment growth and the ArmadaCare acquisition.
Insurance Distribution revenue grew 77% year-over-year, with organic growth of 44% and contributions from the ArmadaCare acquisition.
Net loss to shareholders improved to $(14.4) million from $(20.5) million in Q2 2025, reflecting better segment performance.
Adjusted EBITDA to shareholders rose to $3.7 million from $(4.6) million year-over-year, with significant contributions from Insurance Distribution and Specialty P&C segments.
AI-driven underwriting platform launched, reducing quote times and expected to drive efficiency and growth.
Financial highlights
Insurance Distribution segment revenue reached $58.4 million, with organic revenue growth of 44%.
Specialty P&C Insurance segment net premiums written increased 52% to $23 million, while gross premiums written declined 2% to $95 million.
Net income for Specialty P&C Insurance was $1.1 million, up from $0.4 million year-over-year.
Adjusted EBITDA to shareholders for Insurance Distribution was $9.8 million, up from $2.5 million; for Specialty P&C, $1.8 million, up from $0.7 million.
Consolidated adjusted EBITDA improved to $3.7 million from -$4.6 million in Q2 2025.
Outlook and guidance
Raised Insurance Distribution organic growth guidance to 25%+ (from 20%+) and adjusted EBITDA to $45 million (from $40 million).
Everspan adjusted EBITDA guidance revised to $6 million (from $7.5 million) due to higher acquisition costs.
Adjusted net income per share guidance updated to $0.15–$0.20 (from $0.50), reflecting refined estimates.
Management expects the new AI-driven underwriting platform to accelerate and improve underwriting decisions and bring additional MGAs to market faster.
2026 expected to be first year of positive adjusted net income per share since P&C strategy launch.
Latest events from Octave Specialty Group
- Executing rapid global MGA growth with strong financials and a scalable, partnership-driven model.OSG
Investor presentation - Director elections, strategic transformation, and AI-driven growth initiatives were key highlights.OSG
AGM 2026 - Transformation completed, compensation aligned, and Board urges support for all proxy proposals.OSG
Proxy filing - Insurance Distribution revenue up 92%, total revenue up 66%, and adjusted EBITDA surged.OSG
Q1 2026 - Shareholders to vote on board, compensation, auditor, and new incentive plan after major transformation.OSG
Proxy filing - Board recommends approval of all annual meeting proposals, including director elections and compensation.OSG
Proxy filing - Q4 2025 delivered strong premium and revenue growth, but net loss rose on acquisition costs.OSG
Q4 2025 - AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 2024 - Revenue and premium up sharply, but net loss widened; Legacy/AAC sale pending approval.OSG
Q1 2025